ActiveMSers Forums  

Go Back   ActiveMSers Forums > ActiveMSers.org Forums > Dave's SCT Journey

Reply
 
Thread Tools Display Modes
  #1  
Old 05-16-2019, 04:35 PM
ActiveMSers's Avatar
ActiveMSers ActiveMSers is offline
Dave @ ActiveMSers
 
Join Date: Jun 2008
Location: Albuquerque, NM
Posts: 3,719
Default BOOK CHAPTER: HSCT for Autoimmune Diseases—Specific Diseases and Controversies

Autologous Hematopoietic Cell Transplants for
Autoimmune Diseases: Specific Diseases and
Controversies


L.C.M. Arruda, M.C. Oliveira, K.C.R. Malmegrim, E. Gluckman, and D. Farge

Introduction
Autologous hematopoietic cell transplantation (auto-HCT) has been intensely investigated as a new therapeutic approach for autoimmune diseases (ADs). Almost 20 years after the first transplant, concise data show that auto-HCT can induce longterm disease stabilization and this new therapeutic approach has been increasingly accepted in several ADs for its combination of safety and efficacy[1–5]. More than 2000 AD patients worldwide (European Blood and Marrow Transplant (EBMT), Center for International Blood and Marrow Research (CIBMTR), Asian registry) have already undergone hematopoietic cell transplantation, mainly autologous, for treatment of AD[3–12], including multiple sclerosis (MS)[13–28], systemic sclerosis (SSc)[29–34], Crohn’s disease (CD)[35–39], systemic lupus erythematosus (SLE)[40–44], and type 1 diabetes (T1D)[45–47], among others[3,5,7,8,48].

FULL CHAPTER AS PDF:
https://www.researchgate.net/profile...troversies.pdf
__________________
Dave Bexfield
ActiveMSers
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 01:17 PM.


Powered by vBulletin® Version 3.7.0
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
ActiveMSers